Michigan-Based Cancer Drug Identification Company Intervention Insights Raises $7.2 Million

Intervention Insights is a Grand Rapids, Michigan based company that has raised $7.2 million to build and commercialize software that would help doctors identify the proper drugs to create specific types of cancer. Investors in this round include Farmington Hills, Michigan based private equity company Beringea, and Kentucky-based Chrysalis Ventures. The Hopen Life Sciences and Michigan Accelerator Fund I also participated in this round.

“It’s a really strong syndicate,” stated Beringea managing director Michael Gross. Gross and Chrysalis Ventures managing director Koleman Karleski, will be joining the board of directors at Intervention Insights. Intervention Insights was founded in 2009. The funding will be used to expand sales.

[Xconomy]

Related posts:

1. Michigan Based Private Equity Firm Beringea Invests $4.2 Million In MatsSoft
2. Michigan-Based EcoMotors Raises $18 Million From Zhongding and Global Optima
3. Michigan-Based Towing Company Suing Student Over Facebook Group
4. Location-Based Game Company SCVNGR Raises $4 Million From Google Ventures and Highland Capital
5. Ann Arbor Based Mobile Security Company Scio Security Raises $1 Million